Position Rituxan as the standard of care for the treatment of Follicular Non-Hodgkin’s Lymphoma (NHL) at any stage (first line, maintenance, relapse) and to raise awareness among patients, leading to a higher intention to take action.

• Consumer push, physician pull strategy
  Targeted both patients and professionals, to create demand while ensuring high-quality care and informed decision-making
• KOL engagement
  Involved KOLs in roundtable discussions and used them as influencers to endorse Rituxan and its new treatment strategies.
• Trade-media outreach
  Shared thought-provoking stories and updates on Rituxan, fostering heightened curiosity and attention.
• Advocacy mobilization
  Enhanced collaboration with patient advocacy groups to disseminate information about Rituxan and support their efforts in educating patients.
• Consumer campaign
  Focused on patient success stories to showcase the effectiveness and relevance of Rituxan in their treatment journey.

• Generated a positive shift in the perception of Rituxan as the go-to treatment for follicular NHL patients, helping to put them in the driver’s seat of their treatment journey.
• Increased uptake of Rituxan as a standard of care in the targeted population. Positive feedback from healthcare providers and patients alike.
• Media coverage in leading healthcare publications and outlets.